logo
  

Toyota Motor Announces Additional Suspensions Of Domestic Plant Production In Japan

Toyota Motor Corp. (TYT.L,TM) announced additional suspensions of domestic plant production for completed vehicles in Japan on January 21, 22 and 24. The company said the decision is due to the shortage of parts supply caused by the spread of COVID-19 at its suppliers in Japan. This production suspension on Friday, Saturday and Monday affects 20 lines in 11 plants out of 28 lines in 14 plants, the company noted.

The company said the adjustments to domestic production involves specified production line at Motomachi Plant, Takaoka Plant, Tsutsumi Plant, Tahara Plant, Iwate Plant, Miyagi Ohira Plant, Fujimatsu Plant, Inabe Plant, Yoshiwara Plant, Gifu Auto Body and Hamura Plant.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT